Skip to content

Clinical trials

Phase 2 Retinoblastoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinoblastoma Phase: Phase 2 Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20061
20071
20091
20101
20111
20131
20191
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting3
Terminated2
Withdrawn2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center5
St. Jude Children's Research Hospital3
National Cancer Institute (NCI)2
Ann & Robert H Lurie Children's Hospital of Chicago1
Children's Oncology Group1
Endeavor Biomedicines, Inc.1
M.D. Anderson Cancer Center1
Medical College of Wisconsin1
NYU Langone Health1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinoblastoma19
Sarcoma8
Neuroblastoma7
Osteosarcoma6
Central Nervous System Neoplasms5
Medulloblastoma4
Ovarian Neoplasms4
Chondrosarcoma3
Desmoplastic Small Round Cell Tumor3
Neuroectodermal Tumors, Primitive, Peripheral3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.